新里程(002219) - 2025 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2025 was ¥668,205,837.80, a decrease of 29.26% compared to the same period last year[5] - The net profit attributable to shareholders was a loss of ¥45,899,265.40, representing a decline of 604.29% year-on-year[5] - Basic earnings per share were -¥0.0136, down 615.79% from the previous year[5] - The company reported a net loss of CNY 3,001,573,674.46, compared to a net loss of CNY 2,963,105,462.22 in the previous period[17] - The company reported a net loss of ¥39,273,609.59, compared to a net profit of ¥64,236,567.81 in the previous period, indicating a significant decline in profitability[22] - Operating income decreased to ¥1,840,736.52 from ¥83,693,091.17 year-over-year, reflecting a substantial drop in operational performance[22] - The company’s total comprehensive income was -¥39,273,609.59, compared to ¥64,236,567.81 in the previous period, highlighting a significant downturn in overall financial health[22] Assets and Liabilities - Total assets at the end of the reporting period were ¥6,553,494,556.46, a decrease of 1.85% from the end of the previous year[5] - Total assets decreased to CNY 6,553,494,556.46 from CNY 6,677,192,220.41, a reduction of 1.9%[19] - Current liabilities totaled CNY 3,397,056,008.22, down 4.4% from CNY 3,554,245,324.97[17] - Non-current liabilities increased to CNY 1,133,244,612.46 from CNY 1,082,217,261.47, an increase of 4.7%[17] - The company’s total equity decreased to CNY 2,023,193,935.78 from CNY 2,040,729,633.97, a decline of 0.9%[19] - The total equity attributable to shareholders decreased by 0.84% to ¥1,968,248,965.17[5] Cash Flow - The company reported a net cash flow from operating activities of ¥150,956,067.08, down 31.88% year-on-year[5] - Cash flow from operating activities generated ¥150,956,067.08, down from ¥221,602,100.83 in the previous period, showing a decrease of approximately 32%[23] - The company incurred total operating cash outflows of ¥2,168,439,165.33, compared to ¥2,699,237,920.23 in the previous period, reflecting a reduction in cash outflows[23] - The company’s financing activities generated a net cash inflow of ¥71,168,098.79, contrasting with a net outflow of -¥208,419,983.73 in the previous period, suggesting improved financing conditions[24] Research and Development - Research and development expenses increased by 61.69% to ¥12,149,790.69 due to higher external R&D spending[8] - Research and development expenses rose to CNY 12,149,790.69, up from CNY 7,514,256.13, reflecting a 61.5% increase[20] Shareholder Information - The total number of common shareholders at the end of the reporting period was 69,301, with no preferred shareholders having restored voting rights[11] - The largest shareholder, Beijing New Mileage Health Industry Group Co., Ltd., holds 24.38% of shares, amounting to 825,927,323 shares, with 310,625,970 shares pledged[11] - The second-largest shareholder, Minmetals Jintong Equity Investment Fund Management Co., Ltd., holds 4.91% of shares, totaling 166,391,223 shares[11] - The company has no preferred shareholders or significant changes in the top ten shareholders participating in margin trading[12] Government Subsidies and Other Income - The company reported a total of ¥1,880,599.39 in government subsidies recognized during the reporting period[6] - The company received cash from other operating activities amounting to approximately ¥59.78 million, a 144.54% increase compared to the previous period[9] - The company received ¥112.7 million from investments, marking a 100.00% increase from the previous period due to funds from priority partners[9] Financing Activities - Cash received from financing activities rose by 100.82% to ¥238.28 million, attributed to an increase in non-bank financing[9] - Cash paid for financing activities increased by 55.14% to ¥288.45 million, primarily for the repayment of employee loans and other non-bank financing[9] - Cash paid for the acquisition of subsidiaries increased dramatically by 3100.00% to ¥160 million, indicating a substantial investment in subsidiary equity acquisition[9] - The net cash received from the disposal of subsidiaries was ¥521.92, reflecting a significant decrease of 99.98% due to the disposal of subsidiaries during the reporting period[9]